These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23318604)

  • 1. Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study.
    Bellot P; Welker MW; Soriano G; von Schaewen M; Appenrodt B; Wiest R; Whittaker S; Tzonev R; Handshiev S; Verslype C; Moench C; Zeuzem S; Sauerbruch T; Guarner C; Schott E; Johnson N; Petrov A; Katzarov K; Nevens F; Zapater P; Such J
    J Hepatol; 2013 May; 58(5):922-7. PubMed ID: 23318604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of refractory ascites by the automated low flow pump system (Alfapump)].
    Restellini S; Soares PC; Giostra E; Spahr L
    Rev Med Suisse; 2014 Sep; 10(440):1607-8, 1610-1. PubMed ID: 25276999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
    Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
    N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.
    Bureau C; Adebayo D; Chalret de Rieu M; Elkrief L; Valla D; Peck-Radosavljevic M; McCune A; Vargas V; Simon-Talero M; Cordoba J; Angeli P; Rosi S; MacDonald S; Malago M; Stepanova M; Younossi ZM; Trepte C; Watson R; Borisenko O; Sun S; Inhaber N; Jalan R
    J Hepatol; 2017 Nov; 67(5):940-949. PubMed ID: 28645737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
    Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
    Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated low flow pump system for the treatment of refractory ascites: a single-center experience.
    Thomas MN; Sauter GH; Gerbes AL; Stangl M; Schiergens TS; Angele M; Werner J; Guba M
    Langenbecks Arch Surg; 2015 Dec; 400(8):979-83. PubMed ID: 26566989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated low-flow ascites pump in a real-world setting: complications and outcomes.
    Solbach P; Höner Zu Siederdissen C; Wellhöner F; Richter N; Heidrich B; Lenzen H; Kerstin P; Hueper K; Manns MP; Wedemeyer H; Jaeckel E
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1082-1089. PubMed ID: 29738325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis.
    Stirnimann G; Berg T; Spahr L; Zeuzem S; McPherson S; Lammert F; Storni F; Banz V; Babatz J; Vargas V; Geier A; Stallmach A; Engelmann C; Trepte C; Capel J; De Gottardi A
    Aliment Pharmacol Ther; 2017 Nov; 46(10):981-991. PubMed ID: 28940225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.
    Alessandria C; Elia C; Mezzabotta L; Risso A; Andrealli A; Spandre M; Morgando A; Marzano A; Rizzetto M
    Dig Liver Dis; 2011 Nov; 43(11):881-6. PubMed ID: 21741331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The North American Study for the Treatment of Refractory Ascites.
    Sanyal AJ; Genning C; Reddy KR; Wong F; Kowdley KV; Benner K; McCashland T;
    Gastroenterology; 2003 Mar; 124(3):634-41. PubMed ID: 12612902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.
    Albillos A; Bañares R; González M; Catalina MV; Molinero LM
    J Hepatol; 2005 Dec; 43(6):990-6. PubMed ID: 16139922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
    Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J
    Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
    Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
    Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
    Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
    N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical shunts and TIPS for variceal decompression in the 1990s.
    Henderson JM; Nagle A; Curtas S; Geisinger M; Barnes D
    Surgery; 2000 Oct; 128(4):540-7. PubMed ID: 11015086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment.
    Crenshaw WB; Gordon FD; McEniff NJ; Perry LJ; Hartnell G; Anastopoulos H; Jenkins RL; Lewis WD; Wheeler HG; Clouse ME
    Radiology; 1996 Jul; 200(1):185-92. PubMed ID: 8657908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.